Hospital
The First Affiliated Hospital of Fujian Medical University福建医科大学附属第一医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
Fudan University hospital rankings A++ General list, 2023
-
Published research 19 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 7 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
Fudan University hospital rankings
| Item | Rank / tier | Year | Caliber | Source |
|---|---|---|---|---|
| General list | A++ | 2023 | Tier only; hospitals in the same tier are not ordered against each other | https://rank.cn-healthcare.com/fudan/national-general |
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 福建医科大学附属第一医院
- English name
- The First Affiliated Hospital of Fujian Medical University
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Also known as
- First Affiliated Hospital of Fujian Medical University
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- Metabolic dynamic score and machine learning: a novel approach to predicting pathological complete response in rectal cancer after neoadjuvant chemoradiotherapy. Frontiers in oncology, 2026
- Relationship between ostomy caregiver skill proficiency and one-month risk of ostomy complications in patients with colorectal cancer: A cohort study. PloS one, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
-
Breast cancer
Published research
- In vitro characterization of a novel anti-GD2/ROR1 bispecific antibody exhibiting tumor cell killing efficacy in neuroblastoma cross-cancer activity in ROR1-positive triple-negative breast cancer. Translational cancer research, 2026
- From Label-Free Multiphoton Imaging to Pathological Reports: A Vision-Language Breast Cancer Margin Pathological Diagnosis System. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026
3 more published studies
PubMed indexes 5 papers on this condition that name this hospital.
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
-
Lung cancer
Published research
- Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP). Clinical & experimental metastasis, 2026
- Treatment patterns and outcomes of later-line therapy in advanced non-small cell lung cancer with unknown or no actionable genomic alterations: a multicenter real-world study in China (RECAP study). Translational lung cancer research, 2026
2 more published studies
PubMed indexes 4 papers on this condition that name this hospital.
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
-
Liver cancer
Published research
- Development and validation of GADA model for diagnosing hepatocellular carcinoma in Chinese hepatitis B patients. Chinese medical journal, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
-
Stomach cancer
Published research
- METTL7A Downregulation Drives SLC1A5-Mediated Glutamine Competition to Promote Tumor Proliferation and Suppress CD8(+) T Cell Immunity in Gastric Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026
- Ubiquitin Specific Peptidase 48 Deubiquitinates METTL3 to Modulate Ferroptosis in Gastric Cancer Cells. Molecular carcinogenesis, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
-
Prostate cancer
Published research
- Transition Zone Prostate Cancer: Quantitative Synthetic MR Imaging and Diffusion-Weighted Imaging in Tumour Detection. Journal of medical imaging and radiation oncology, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
-
Nasopharyngeal carcinoma
Published research
- P-MES: Explainable pathology-based distant metastasis risk stratification in locally advanced nasopharyngeal carcinoma. Digital health, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
-
Esophageal cancer
Published research
- Data-driven prognostic factors analysis and personalized follow-up strategies for post-progression survival in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy. Annals of medicine, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Nuclear Medicine 核医学 nominated in the Fudan list.
Other hospitals in Fuzhou
Source & evidence
- Source URL
- https://rank.cn-healthcare.com/fudan/national-general
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24